Variables | Total Patients (n = 4504) | Patients with LDL-C on target (n = 922, 20.5%) | Patients with LDL-C not on target (n = 3582, 79.5%) | p |
---|---|---|---|---|
Gender (Female n,%) | 2639 (58.6) | 475 (51.5) | 2164 (60.4) | < 0.001 |
Age (year) | 58.6 ± 10.4 | 58.4 (±10.5) | 58.6 (±10.4) | 0.68 |
BMI (kg/m2) | 32.1 ± 6.5 | 31.8 (±6.6) | 32.1 (±6.4) | 0.12 |
SBP (mmHg) | 132.5 ± 18.3 | 131.4 (±18.1) | 132.8 (±18.4) | 0.03 |
DBP (mmHg) | 80.5 ± 10.7 | 80.0 (±10.7) | 80.6 (±10.7) | 0.17 |
Diabetes duration (year) | 10.9 ± 7.5 | 10.8 (±7.4) | 11.0 (±7.5) | 0.46 |
Active smoking (n,%) | 561 (12.5) | 119 (13.0) | 442 (12.4) | 0.61 |
HbA1c (%) | 7.73 ± 1.74 | 7.60 (±1.64) | 7.75 (±1.77) | 0.015 |
HbA1c levels < 7% | 1790 (40.2) | 390 (42.7) | 1400 (39.5) | 0.085 |
Exercise (n,%) | 883 (19.6) | 226 (24.7) | 657 (18.6) | < 0.001 |
Higher education (n,%) | 1722 (38.2) | 369 (40.4) | 1353 (38.4) | 0.26 |
Private center follow-up (n,%) | 483 (10.2) | 123 (13.3) | 342 (9.5) | 0.001 |
Microvascular complications (n,%) | 2142 (47.6) | 222 (24.1) | 1920 (53.6) | < 0.001 |
Retinopathy (n,%) | 874 (21.3) | 107 (12.5) | 767 (23.7) | < 0.001 |
Nephropathy (n,%) | 817 (19.6) | 84 (9.7) | 733 (22.2) | < 0.001 |
Neuropathy (n,%) | 1545 (34.7) | 163 (17.9) | 1382 (39.0) | < 0.001 |
Macrovascular complications (n,%) | 1103 (24.5) | 165 (17.9) | 938 (26.2) | < 0.001 |
Coronary artery disease (n,%) | 962 (21.4) | 151 (17.7) | 811 (24.5) | < 0.001 |
Peripheral artery disease (n,%) | 175 (4.2) | 28 (3.2) | 147 (4.4) | 0.11 |
Cerebrovascular disease (n,%) | 132 (3.0) | 19 (2.1) | 113 (3.3) | 0.07 |
Obesity (n,%) | 2593 (58.3) | 472 (51.7) | 2027 (56.8) | 0.005 |
Hypertension (n,%) | 3074 (68.6) | 621 (67.8) | 2453 (68.8) | 0.58 |
Blood pressure on target (n,%) | 3128 (69.9) | 668 (73.1) | 2460 (69.1) | 0.020 |
LDL-Cholesterol (mg/dl) | 113.9 (±36.2) | 73.8 (±17.1) | 124.2 (±32.4) | < 0.001 |
HDL-Cholesterol (mg/dl) | 46.5 (±12.9) | 45.5 (±14.7) | 46.9 (±12.4) | 0.005 |
HDL- Cholesterol on target (n,%) | 1978 (43.9) | 376 (41.8) | 1602 (46.8) | 0.007 |
Triglycerides (mg/dl) | 182.1 (±128.7) | 164.0 (±113.7) | 181.4 (±115.8) | < 0.001 |
Triglycerides on target (n,%) | 2272 (50.4) | 529 (57.8) | 1743 (48.8) | < 0.001 |
Statin treatment (n,%) | 1807 (40.1) | 448 (48.6) | 1359 (37.9) | < 0.001 |
High intensity statin (n,%) | 181 (4.0) | 41 (22.7) | 140 (77.3) | 0.48 |